We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 981

U.S. Supreme Court Accepts Appeal of First Inter Partes Review Decision: Could Mark a Significant Turning Point in Claim Construction at the PTAB
  • Foley & Lardner LLP
  • USA
  • January 19 2016

The U.S. Supreme Court accepted its first appeal from the Federal Circuit involving an inter partes review (IPR) styled Cuozzo Speed v. Lee, which is


Supreme Court Accepts 1st IPR Appeal: Cuozzo Could Mark Turning Point for Patent Owners
  • Foley & Lardner LLP
  • USA
  • January 16 2016

Yesterday the Supreme Court granted certiorari in Cuozzo Speed v. Lee, which represents the first time the high Court will address an AIA proceeding


Denying Prior Art Status In PTAB Proceedings: Petitioner's Failure to Show Section 112 Support in Priority Applications May Be Fatal
  • Foley & Lardner LLP
  • USA
  • January 15 2016

Several of our recent posts have discussed petitioners' use of priority denial to attack patents with intervening prior art, but the issue of


PTAB Trial Standard Of Review Requires Affirmance Despite Contrary Evidence
  • Foley & Lardner LLP
  • USA
  • January 14 2016

In Merck & Cie v. Gnosis S.p.A., the Federal Circuit affirmed the decision of the USPTO Patent Trial and Appeal Board (PTAB) that held the challenged


Losing Competing Property Not A Teaching Away
  • Foley & Lardner LLP
  • USA
  • January 12 2016

In In re Urbanski, the Federal Circuit upheld the decision of the USPTO Patent Trial and Appeal Board (PTAB) finding the claims of Urbanski's patent


Federal Circuit Backs PTAB Decision Curtailing A Party's Use Of "Supplemental" Information
  • Foley & Lardner LLP
  • USA
  • January 7 2016

In Redline Detection v. Star Envirotech, the Federal Circuit confirmed that the PTAB can decline to consider timely filed "supplemental" information


Share Your Patent Quality Pet Peeves
  • Foley & Lardner LLP
  • USA
  • January 7 2016

The USPTO is inviting stakeholders to suggest topics for patent quality case studies. As explained in the December 21, 2015 Federal Register Notice


Did The PTAB Dose The AIA Poison Pill Incorrectly Against Premium Genetics?
  • Foley & Lardner LLP
  • USA
  • January 4 2016

In Inguran, LLC v. Premium Genetics (UK) Ltd., the USPTO Patent Trial and Appeal Board (PTAB) instituted Post Grant Review (PGR) proceedings in a


Use of Priority Denial to Subject Apparent "Pre-AIA" Patents to PGR: Inguran v. Premium Genetics
  • Foley & Lardner LLP
  • USA
  • December 30 2015

A recent decision by the PTAB, Inguran v. Premium Genetics, demonstrates that a Petitioner may subject an apparent "pre-AIA" patent, having at least


Don't Blame Patents For High Drug Prices
  • Foley & Lardner LLP
  • USA
  • December 29 2015

Before his recent arrest, Martin Shkreli, the former CEO of Turing Pharmaceuticals, gained notoriety for increasing the price of the AIDS drug